Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew

1 Issue per year

IMPACT FACTOR 2016 (Open Medicine): 0.294
IMPACT FACTOR 2016 (Central European Journal of Medicine): 0.116

CiteScore 2016: 0.28

SCImago Journal Rank (SJR) 2015: 0.140
Source Normalized Impact per Paper (SNIP) 2015: 0.154

Open Access
See all formats and pricing
More options …
Volume 2, Issue 4


Differential course of HIV-1 infection and apolipoprotein E polymorphism

Elizabeth Corder / Luciano Galeazzi / Claudio Franceschi / Andrea Cossarizza / Roberto Paganelli / Marcello Pinti / Cristina Mussini / Vanni Borghi / Elena Pinter / Rita Cristofaro / Roberta Galeazzi / Marino Perini / Fernando Aiuti / Sergio Giunta
Published Online: 2007-12-01 | DOI: https://doi.org/10.2478/s11536-007-0039-x


We studied the course of infection with human immunodeficiency virus type 1 (HIV-1) in relation to apolipoprotein E (APOE) polymorphism found for 209 Italians treated at Infectious Disease Clinics in Rome and Modena. Clinically, patients were classified into four groups according to the yearly rate of decline in CD4+ cell count (LTNP: long-term non-progression; SLOW, ’NORMAL’ or RAPID). Patients at both extremes of the clinical spectrum, i.e. those who rapidly progressed to AIDS and those with stable high CD4 cell counts, had few APOE ɛ4 and ɛ2 alleles (P = 0.04). Detailed clinical information was then used to construct four model-based clinical profiles using grade-of-membership analysis (GoM), predictive of APOE genotypic frequencies: 1. The clinical profile associated with good long-term prognosis lacked ɛ2 (P=0.01); 2. Disease progression to AIDS was associated with ɛ4 and ɛ2, most evident for zidovudine-lamivudine regimens without a protease inhibitor (P = 0.03); and, 3. AIDS patients had low ɛ4 and ɛ2 frequencies, consistent with a high mortality rate among ɛ4+ and ɛ2+ AIDS patients. These findings suggest allele-specific immunomodulatory effects involving inherited APOE isoform important enough to alter the clinical course of HIV infection and, possibly, drug efficacy. They imply a connection between lipid metabolism and immunity potentially relevant to common disorders.

Keywords: HIV-1 infection; APOE; genetic epidemiology; grade-of-membership analysis; immunomodulation

  • [1] R.W. Mahley: “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology”, Science, Vol. 240 (1988), pp. 622–630. http://dx.doi.org/10.1126/science.3283935CrossrefGoogle Scholar

  • [2] E.M. Avila, G. Holdsworth, N. Sasaki, R.L. Jackson and J.A. Harmony: “Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells”, J. Biol. Chem., Vol. 257, (1982), pp. 5900–5909. Google Scholar

  • [3] M.G. Pepe and L.K. Curtiss: “Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In”, J. Immunol., Vol. 136, (1986), pp. 3716–3723. Google Scholar

  • [4] L.K. Curtiss and T.S. Edgington: “The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content”, J. Immunol., Vol 126, (1981), pp. 1382–1386. Google Scholar

  • [5] R.A. Terkeltaub, C.A. Dyer, J. Martin and L.K. Curtiss: “Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo”, J. Clin. Invest., Vol. 87, (1991), pp. 20–26. http://dx.doi.org/10.1172/JCI114971CrossrefGoogle Scholar

  • [6] N. de Bont, P.N. Demacker, B.J. Kullberg, J.W. van der Meer and A.F. Stalenhoef: “Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae”, Eur. J. Clin. Invest., Vol. 30, (2000), pp. 818–822. http://dx.doi.org/10.1046/j.1365-2362.2000.00715.xCrossrefGoogle Scholar

  • [7] S.E. Roselaar and A. Daugherty: “Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo”, J. Lipid. Res., Vol 39, (1998), pp. 1740–1743. Google Scholar

  • [8] D.T. Laskowitz, D.M. Lee, D. Schmechel and H.F. Staats: “Altered immune responses in apolipoprotein E-deficient mice”, J. Lipid. Res., Vol. 41, (2000), pp. 613–620. Google Scholar

  • [9] B. Ludewig, M. Jäggi, T. Dumrese, K. Brduscha-Riem, B. Odermatt, H. Hengartner and R.M. Zinkernagel: “Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses”, J. Immunol., Vol. 166, (2001), pp. 3369–3376. Google Scholar

  • [10] T. Kuusi, M.S. Nieminen, C. Ehnholm, H. Yki-Järvinen, M. Valle, E.A. Nikkilä and M.R. Taskinen: “Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients”, Arteriosclerosis, Vol. 9, (1989), pp. 237–241. CrossrefGoogle Scholar

  • [11] G. Utermann, A. Hardewig and F. Zimmer: “Apolipoprotein E phenotypes in patients with myocardial infarction”, Hum. Genet., Vol. 65, (1984), pp. 237–241. http://dx.doi.org/10.1007/BF00286509CrossrefGoogle Scholar

  • [12] E.H. Corder, H. Basun, L. Fratiglioni, Z. Guo, L. Lannfelt, M. Viitanen, L.S. Corder, K.G. Manton and B. Winblad: “Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+”, Ann. N. Y. Acad. Sci., Vol. 908, (2000), pp. 295–298. http://dx.doi.org/10.1111/j.1749-6632.2000.tb06657.xCrossrefGoogle Scholar

  • [13] A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan and M.J. Alberts: “Association of apolipoprotein E allele e4 with late onset familial and sporadic Alzheimer’s disease”, Neurology, Vol. 43, (1993), pp. 1467–1472. Google Scholar

  • [14] W.J. Strittmatter, K.H. Weisgraber, D.Y. Huang, L.M. Dong, G.S. Salvesen, M. Pericak-Vance, D. Schmechel, A.M. Saunders, D. Goldgaber and A.D. Roses: “Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 3 allele in late-onset familial Alzheimer disease”, Proc. Natl. Acad. Sci. USA, Vol. 90, (1993), pp. 1977–1981. http://dx.doi.org/10.1073/pnas.90.5.1977CrossrefGoogle Scholar

  • [15] E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. Pericak-Vance: “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families”, Science, Vol. 261, (1993), pp. 921–923. http://dx.doi.org/10.1126/science.8346443CrossrefGoogle Scholar

  • [16] C. Ballerini, D. Campani, G. Rombola, B. Gran, B. Nacmias, M.P. Amato, G. Siracusa, L. Bartolozzi, S. Sorbi and L. Massacesi: “Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis”, Neurosci. Lett., Vol. 296, (2000), pp. 174–176. http://dx.doi.org/10.1016/S0304-3940(00)01646-3CrossrefGoogle Scholar

  • [17] T. Masterman, J. Hillert, L. Lannfelt and E.H. Corder: “The 4 allele for APOE doubles the risk of poor long-term prognosis in multiple sclerosis”, Am. J. Hum. Genet., Vol. 67, (2000), pp. S1957. Google Scholar

  • [18] J. Chapman, S. Vinokurov, A. Achiron, D.M. Karussis, K. Mitosek-Szewczyk, M. Birnbaum, D.M. Michaelson and A.D. Korczyn: “APOE genotype is a major predictor of long-term progression of disability in MS”, Neurology, Vol. 56, (2001), pp. 312–316. Google Scholar

  • [19] H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O’Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk and T. Wyss-Coray: “Inflammation and Alzheimer’s disease”, Neurobiol. Aging, Vol. 21, (2000), pp. 383–421. http://dx.doi.org/10.1016/S0197-4580(00)00124-XCrossrefGoogle Scholar

  • [20] D.T. Laskowitz, A.D. Thekdi, S.D. Thekdi, S.K. Han, J.K. Myers, S.V. Pizzo and E.R. Bennett: “Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides”, Exp. Neurol., Vol. 167, (2001), pp. 74–85. http://dx.doi.org/10.1006/exnr.2001.7541CrossrefGoogle Scholar

  • [21] J.R. Lynch, D. Morgan, J. Mance, W.D. Matthew and D.T. Laskowitz: “Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response”, J. Neuroimmunol., Vol. 114, (2001), pp. 107–113. http://dx.doi.org/10.1016/S0165-5728(00)00459-8CrossrefGoogle Scholar

  • [22] R.F. Itzhaki, W.R. Lin, D. Shang, G.K. Wilcock, B. Faragher and G.A. Jamieson: “Herpes simplex virus type 1 in brain and risk for Alzheimer’s disease”, Lancet, Vol. 349, (1997), pp. 241–244. http://dx.doi.org/10.1016/S0140-6736(96)10149-5CrossrefGoogle Scholar

  • [23] S. Sorbi, B. Nacmias, S. Piacentini, A. Repice, S. Latorraca, P. Forleo and L. Amaducci: “ApoE as a prognostic factor for post-traumatic coma”, Nat. Med., Vol. 1, (1995), pp. 852. http://dx.doi.org/10.1038/nm0995-852CrossrefGoogle Scholar

  • [24] E.H. Corder, K. Robertson, L. Lannfelt, N. Bogdanovic, G. Eggertsen, J. Wilkins, C. Hall: “HIV-infected subjects who carry the E4 allele for APOE have excess dementia and peripheral neuropathy”, Nat. Med., Vol. 4, (1998), pp. 1182–1184. http://dx.doi.org/10.1038/2677CrossrefGoogle Scholar

  • [25] Y. Liu, M. Jones, C.M. Hingtgen, G. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath and J.J. He: “Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands”, Nat. Med., Vol. 6, (2000), pp. 1380–1387. http://dx.doi.org/10.1038/82199CrossrefGoogle Scholar

  • [26] C. Grunfeld: “Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome”, J. Clin. Endocrinol. Metab., Vol. 82, (1997), pp. 3734–3740. http://dx.doi.org/10.1210/jc.82.11.3734CrossrefGoogle Scholar

  • [27] G. Carrieri, M. Bonafe, M. De Luca, G. Rose, O. Varcasia, A. Bruni, R. Maletta, B. Nacmias, S. Sorbi, F. Corsonello, E. Feraco, K.F. Andreev, A.I. Yashin, C. Franceschi and G. De Benedictis: “Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer’s disease”, Hum. Genet., Vol. 108, (2001), pp. 194–198. http://dx.doi.org/10.1007/s004390100463CrossrefGoogle Scholar

  • [28] E. Girardi, A. Sampaolesi, M. Gentile, G. Nurra and G. Ippolito: “Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy”, J. Acquir. Immune Defic. Syndr., Vol. 25, (2000), pp. 71–76. http://dx.doi.org/10.1097/00042560-200009010-00010CrossrefGoogle Scholar

  • [29] O. Dunlop, A.K. Goplen, K. Liestol, B. Myrvang, H. Rootwelt, B. Christophersen, E.A. Kvittingen and J. Maehlen: “HIV dementia and apolipoprotein E”, Acta Neurol. Scand., Vol. 95, (1997), pp. 315–318. http://dx.doi.org/10.1111/j.1600-0404.1997.tb00217.xCrossrefGoogle Scholar

  • [30] X. Gao, G.W. Nelson, P. Karacki, M.P. Martin, J. Phair, R. Kaslow, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, S.J. O’Brien and M. Carrington: “Effect of a single amino acid change in MHC class 1 molecutes on the rate of progression to AIDS”, N. Engl. J. Med., Vol. 344, (2001), pp. 1668–1675. http://dx.doi.org/10.1056/NEJM200105313442203CrossrefGoogle Scholar

  • [31] R.K. Lister, M. Youle, D.R. Nair, A.F. Winder and M.H.A. Rustin: “Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors”, Lancet, Vol. 353, (1999), pp. 1678. http://dx.doi.org/10.1016/S0140-6736(99)01449-XCrossrefGoogle Scholar

  • [32] E. Bonnet, J.B. Ruidavets, J. Tuech, J. Ferrieres, X. Collet, J. Fauvel, P. Massip and B. Perret: “Apoprotein C-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy”, J. Clin. Endocrinol. Metab., Vol. 86, (2001), pp. 296–302. http://dx.doi.org/10.1210/jc.86.1.296CrossrefGoogle Scholar

  • [33] L.U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I.C. Klausen, P.S. Hansen, Y.A. Kesäniemi and O. Faergeman: “The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study”, Circulation, Vol. 101, (2000), pp. 1366–1371. Google Scholar

  • [34] J.E. Hixson and D.T. Vernier: “Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I”, J. Lipid Res., Vol. 31, (1990), pp. 545–548. Google Scholar

  • [35] Grade of Membership Software: Center for Demographic Studies, Duke University, Durham, NC (1987). Google Scholar

  • [36] K.G. Manton, M.A. Woodbury and H.D. Tolley: Statistical Applications Using Fuzzy Sets, John Wiley & Sons, New York (1994). Google Scholar

  • [37] H. Akaike: “Information theory and an extension of the maximum likelihood principle”, In: Proc. Second Internat. Symp. on Information Theory., Akademiai Kiado, Budapest (1972), pp. 267–281. Google Scholar

About the article

Published Online: 2007-12-01

Published in Print: 2007-12-01

Citation Information: Open Medicine, Volume 2, Issue 4, Pages 404–416, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-007-0039-x.

Export Citation

© 2007 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Andrew J. Levine, Stella E. Panos, and Steve Horvath
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014, Volume 65, Number 4, Page 481
Coro Paisán-Ruiz, Nicole Washecka, Priti Nath, Andrew B. Singleton, and Elizabeth H. Corder
Annals of Human Genetics, 2009, Volume 73, Number 4, Page 391
E. H. Corder, R. Paganelli, S. Giunta, and C. Franceschi
Proceedings of the National Academy of Sciences, 2008, Volume 105, Number 46, Page E87

Comments (0)

Please log in or register to comment.
Log in